Dr. Dragan J. Golijanin, MD

  • Providence, RI
  • Urologist
NPI1841304078PAC ID4789720046
Medicare services, 2024
1,233
Medicare patients, 2024
349
Part D claims, 2024
509
Publications
57
Hospital affiliations
4
Practice address
195 Collyer St, Providence, RI 02904
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Brown Urology, Inc DBA Collyer Street Operatory - HOPD

Acute Care Hospital outpatient department · Providence, Rhode Island

See all 11 affiliations

Find Dr. Golijanin's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Dragan J. Golijanin is a urologist in Providence, Rhode Island

Dr. Golijanin practices at Brown Urology, Inc DBA Collyer Street Operatory - HOPD in Providence, Rhode Island.

Dr. Golijanin's NPI, 1841304078, was assigned on August 17, 2006. Dr. Golijanin holds Rhode Island license MD13767.

NPI and contact details
Medicare PAC ID
4789720046
NPI enumeration date
August 17, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
68
Medical school graduation
1984

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Dragan J. Golijanin practices at Brown Urology, Inc DBA Collyer Street Operatory - HOPD in Providence, Rhode Island

Dr. Golijanin's primary practice is Brown Urology, Inc DBA Collyer Street Operatory - HOPD, at 195 Collyer St, Providence, RI 02904.

  • Brown Urology, Inc DBA Collyer Street Operatory - HOPD
    195 Collyer St, Providence, RI 02904

Source: Dmand AI Affiliation Data

Dr. Dragan J. Golijanin is affiliated with 8 sites of care and 3 medical groups

Dr. Golijanin's primary practice is Brown Urology, Inc DBA Collyer Street Operatory - HOPD in Providence, Rhode Island. Dr. Golijanin is also affiliated with The Miriam Hospital. The medical group on file is Brown Health Medical Group. Dmand AI also links Dr. Golijanin to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account. Dr. Golijanin's employer is on file too: a hospital.

See all 11 affiliations for Dr. Golijanin

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Dragan J. Golijanin's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Golijanin practices, 8 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Brown Urology, Inc DBA Collyer Street Operatory - HOPDAvailable with a free account
+7 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Golijanin practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Dragan J. Golijanin is one of 53 urologists in Rhode Island

Urology is Dr. Golijanin's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Golijanin is licensed in Rhode Island.

Specialties and state licenses

  • Urology, Rhode IslandPrimaryLicense MD13767 · taxonomy 208800000X

Urologists near Dr. Golijanin

Counts of urologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Dragan J. Golijanin billed Medicare for 1,233 services in 2024

CMS data shows 1,233 Medicare services from Dr. Golijanin across 17 procedure codes in 2024, for 349 Medicare patients. Medicare paid $100,738 for them.

Medicare services, 20241,233
Medicare patients349
Paid by Medicare$100,738
Procedure codes17

Dr. Golijanin's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Lab and pathology
2023: 2052024: 475132%
Office and hospital visits
2023: 5172024: 4758%
Surgery
2023: 2362024: 2516%
Imaging
2023: 122024: 32167%

Where Dr. Golijanin's Medicare services took place, 2024

  • In an office1,11791%
  • In a facility1169%

Dr. Golijanin compared with the Rhode Island median for urologists, 2024

  • Dr. Golijanin
  • Rhode Island median
Medicare services
1,233vs 94530% above
Medicare patients
349vs 334Close to median
Part D claims
448vs 458Close to median

Medians across 52 urologists in Rhode Island with Dmand AI profiles that report each measure.

Dr. Golijanin's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Golijanin

Need commercial claims for Dr. Golijanin?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Golijanin and other urologists in Rhode Island.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Dragan J. Golijanin treated 349 Medicare patients in 2024, average age 77

CMS counts 349 Medicare patients who saw Dr. Golijanin in 2024. The largest group is 75 to 84, with 167 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Golijanin's median patient age at 74, with 33% women.

Medicare patients, 2024349
Average age77
Average risk score1.76
Also on Medicaid6%

Dr. Golijanin's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Golijanin's Medicare patients by sex, 2024

  • Women11132%
  • Men23868%

Chronic conditions among Dr. Golijanin's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer53%
  4. Arthritis49%
  5. Chronic kidney disease44%
  6. Ischemic heart disease41%
  7. Diabetes37%
  8. Anxiety30%

Share of Medicare patients with each condition. A patient can have several.

Dr. Golijanin's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 74

Patient panel by sex, all payers

  • Women33%
  • Men67%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Dragan J. Golijanin wrote 509 Medicare Part D claims in 2024

In 2024, Dr. Golijanin wrote 509 Medicare Part D claims for 167 patients. 94% of them were for generic drugs. CMS names the drug for 448 of them, across 9 drugs with 11 or more claims each, at $19,107 in total drug cost. In 2023, CMS named 477 claims across 10 drugs.

Part D claims, 2024509
Drugs named by CMS9
Total drug cost$19,107
Part D patients167

Dr. Golijanin's Part D claims by kind of drug, 2024

  • Generic476 claims94%
  • Brand-name33 claims6%

Dr. Golijanin's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Golijanin's Part D claims, 2024

  • Antibiotics21%105 of 509 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4772024: 4486%

Drugs named by CMS: 9 in 2024, 10 in 2023.

See all prescribing by Dr. Golijanin

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Dragan J. Golijanin scored 0 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Golijanin for performance year 2024, reported individually. Dr. Golijanin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Golijanin as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Golijanin's MIPS scores, performance year 2024

  • 0of 100Final score
  • 0of 100Quality
  • 0of 100Promoting Interoperability
  • 0of 100Improvement Activities
  • 0of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find urologists like Dr. Golijanin by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Dragan J. Golijanin has 57 publications on record

Dmand AI links 57 papers to Dr. Golijanin, published from 2011 to 2025. 2024 was the busiest year, with 14. The most frequent topics are Prostatic Neoplasms, Carcinoma, Renal Cell and Kidney Neoplasms. Dr. Golijanin has published most often in Urology. Dr. Golijanin's most frequent co-authors are Gyan Pareek, MD, Anthony Emmanuel Mega, MD and Boris Gershman, MD.

Papers57
Years published2011 to 2025

Dr. Golijanin's papers by year, 2016 to 2025

Topics Dr. Golijanin writes about most

  • Prostatic Neoplasms
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Urinary Bladder Neoplasms
  • Lymphatic Metastasis
  • Lymph Node Excision
  • Nephrectomy
  • Postoperative Complications

Dr. Golijanin's most frequent co-authors

Recent publications by Dr. Golijanin

See all 57 publications and co-authors

See who Dr. Golijanin researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Golijanin works with, so you can find a warm path to the right urologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Dragan J. Golijanin received $13,357 in industry payments from 2016 to 2022

CMS Open Payments shows 75 general payments to Dr. Golijanin from 21 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 52% of the total. Photocure Inc paid the most, $6,873.

General payments to Dr. Golijanin by program year, 2016 to 2022

General payments to Dr. Golijanin by kind, 2016 to 2022

$13.4Kin total
  • Consulting fees$7,00052%
  • Honoraria$2,50019%
  • Travel and lodging$2,29617%
  • Food and beverage$1,56112%

Companies that paid Dr. Golijanin the most, 2016 to 2022

Share is of all general payments to this clinician.

See all payments to Dr. Golijanin

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Dragan J. Golijanin's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Dragan J. Golijanin

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Dragan J. Golijanin's NPI number?

Dr. Dragan J. Golijanin's NPI number is 1841304078. It was assigned on August 17, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Dragan J. Golijanin?

Dr. Dragan J. Golijanin is a urologist in Providence, Rhode Island. The primary specialty in the NPI Registry is Urology Physician (taxonomy code 208800000X).

Where does Dr. Dragan J. Golijanin practice?

Dr. Golijanin practices at 195 Collyer St, Providence, RI 02904. Dr. Golijanin's primary practice is Brown Urology, Inc DBA Collyer Street Operatory - HOPD in Providence, Rhode Island. Dmand AI also links Dr. Golijanin to 3 hospitals, 3 group practices and clinics and 2 medical groups.

What is Dr. Dragan J. Golijanin's medical license number?

Dr. Golijanin holds Rhode Island license MD13767.

Which hospitals is Dr. Dragan J. Golijanin affiliated with?

Dr. Golijanin is affiliated with The Miriam Hospital. Dmand AI links Dr. Golijanin to 3 more hospitals.

What medical group is Dr. Dragan J. Golijanin part of?

Dr. Golijanin is linked to Brown Health Medical Group. Dmand AI links Dr. Golijanin to 2 more medical groups.

Does Dr. Dragan J. Golijanin accept Medicare?

Yes. CMS data shows Dr. Golijanin billed Medicare for 1,233 services in 2024, and Dr. Golijanin accepts Medicare assignment.

Does Dr. Dragan J. Golijanin offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Golijanin as offering telehealth services.

What is Dr. Dragan J. Golijanin's MIPS score?

Dr. Golijanin's MIPS final score for performance year 2024 is 0 out of 100, reported individually.

How many Medicare patients does Dr. Dragan J. Golijanin see?

CMS counts 349 Medicare patients who saw Dr. Golijanin in 2024, with an average age of 77.

Show 6 more questionsShow fewer questions

What services does Dr. Dragan J. Golijanin bill to Medicare?

In 2024, Dr. Golijanin's most billed Medicare services were office visit, established patient (99214), lab and pathology test (81003) and surgery: urinary system (52000).

What drugs does Dr. Dragan J. Golijanin prescribe most?

In 2024 Medicare Part D data, Dr. Golijanin's most prescribed drugs by claims were Tamsulosin HCl, Finasteride and Cephalexin.

Has Dr. Dragan J. Golijanin received payments from drug or device companies?

CMS Open Payments shows $13,357 in general payments to Dr. Golijanin from 21 companies from 2016 to 2022. The largest total came from Photocure Inc.

How long has Dr. Dragan J. Golijanin been practicing?

Dr. Golijanin graduated from medical school in 1984, 42 years ago.

Does Dr. Dragan J. Golijanin do research?

Dmand AI links 57 publications to Dr. Golijanin, published from 2011 to 2025.

Who does Dr. Dragan J. Golijanin publish with?

Dr. Golijanin's most frequent co-authors are Gyan Pareek, MD (15 shared papers), Anthony Emmanuel Mega, MD (14 shared papers) and Boris Gershman, MD (12 shared papers).

Selling to urology practices?

See urologists in Rhode Island by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)